Broughton Laboratories, a UK-based contract laboratory, has launched a new inhalation testing service aimed at helping companies meet the regulatory requirements for inhaled drug products. The launch comes at a great time given that demand for inhaled drug products is on the rise, particularly due to the COVID-19 pandemic, which has highlighted the importance of respiratory treatments.
The service is designed to support pharmaceutical and biotech companies in the development and testing of inhaled products, such as inhalers, nebulizers, and nasal sprays. By offering a range of analytical and physical testing services, Broughton aims to help companies ensure the safety, efficacy, and quality of their products. With its new inhalation testing service, Broughton is poised to play a vital role in the development and delivery of safe and effective inhaled therapies.
Read the full article by med-technews.com here: med-technews.com/broughton